Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Net Cash Flow (2021 - 2025)

Rxo's Net Cash Flow history spans 5 years, with the latest figure at -$8.0 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 55.56% year-over-year to -$8.0 million; the TTM value through Dec 2025 reached -$19.0 million, down 159.38%, while the annual FY2025 figure was -$19.0 million, 159.38% down from the prior year.
  • Net Cash Flow reached -$8.0 million in Q4 2025 per RXO's latest filing, down from $7.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $166.0 million in Q2 2022 to a low of -$100.0 million in Q4 2023.
  • Average Net Cash Flow over 5 years is -$687500.0, with a median of $500000.0 recorded in 2021.
  • Peak YoY movement for Net Cash Flow: crashed 8600.0% in 2022, then skyrocketed 352.63% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at -$1.0 million in 2021, then plummeted by 8600.0% to -$87.0 million in 2022, then decreased by 14.94% to -$100.0 million in 2023, then soared by 82.0% to -$18.0 million in 2024, then skyrocketed by 55.56% to -$8.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Net Cash Flow are -$8.0 million (Q4 2025), $7.0 million (Q3 2025), and $2.0 million (Q2 2025).